Rapid-acting Treatments for Pediatric Depression and Suicidality: Where are We Now?
Offered By: Brown University via Independent
Course Description
Overview
Jennifer B. Dwyer, MD, PhD
Co-Director Yale Pediatric Depression Program
Assistant Professor, Child Study Center and Dept of Radiology and Biomedical Imaging
Yale University
Syllabus
- Describe the proposed mechanism of action of novel rapid-acting anti-depressant and anti-suicidal pharmacotherapeutics
- Describe the state of the pediatric evidence base for rapid-acting treatments and to compare it with the adult evidence base
- Appreciate the unique developmental considerations that apply to testing and implementing novel therapeutics in the pediatric population
Tags
Related Courses
The 51st Meeting of the NH/VT Ethics Committees: Navigating Decision-Making Capacity amid Mental Illness Uncomfortable Ethical Quandaries Inherent When Psychiatrically Ill Children are Boarded on Non-psychiatric Pediatric Floors Part 3 of 4Dartmouth College via Independent 80028094 - JHACH On-Demand CME 32522: American Board of Pediatrics, Maintenance of Certification (MOC) & Portfolio Sponsor Kathy Renn, MS, ARNP; Fauzia Shakeel, MD, FAAP, CPHQ
Johns Hopkins University via Independent 80028094 - JHACH On-Demand CME 32522: Behavioral Health in Pediatric Gender Affirming Care Jonathan Poquiz, PhD
Johns Hopkins University via Independent 80028094 - JHACH On-Demand CME 32522: Hereditary Hemorrhagic Telangiectasia (HHT) The Disease, Its Inheritance, and the Pediatric Population Sally E. Mitchell, MD, FSIR, FCIRSE
Johns Hopkins University via Independent 80028094 - JHACH On-Demand CME 32522: Panic and Anxiety Disorders in Pediatrics: Diagnosis and Management Reena Thomas, MD, FAPA
Johns Hopkins University via Independent